Table 1b.
Gender and drug status for BDI and BDII diagnosis groups.
| N=279 | BD-I (N=183) | BD-II (N=96) | Comparison test |
|
|---|---|---|---|---|
| Count +(−) | Count +(−) | χ2 | p | |
| Female (Male) | 123 (60) | 67 (29) | .19 | .66 |
| Lithium (N=234) | 55 (94 free) | 21 (64 free) | 3.68 | .055 |
| Anticonvulsants (N=233) | 63 (86 free) | 33 (51 free) | .20 | .66 |
| Antipsychotics (N=235) | 74 (77 free) | 33 (51 free) | 2.06 | .15 |
| Antidepressants (N=231) | 47 (100 free) | 40 (44 free) | 5.57 | .018 |
| Benzodiazepines (N=238) | 22 (131 free) | 12 (73 free) | .01 | .91 |
| Drug free (N=233) | 15 (133 any drug) | 9 (76 any drug) | .01 | .96 |